|
US487000A
(en)
|
|
1892-11-29 |
|
Shirt |
|
US2832685A
(en)
|
1952-05-24 |
1958-04-29 |
Crest Foods Co Inc |
Solubilization of milk proteins
|
|
GB894095A
(en)
|
1960-02-08 |
1962-04-18 |
Tanaka Shoichi |
A therapeutic device for personal wear
|
|
US3528960A
(en)
|
1968-10-07 |
1970-09-15 |
Lilly Co Eli |
N-carboxyaroyl insulins
|
|
US3719655A
(en)
|
1969-12-05 |
1973-03-06 |
Lilly Co Eli |
Process for the crystallization of the ammonium and alkali metal salts in insulin
|
|
US3869437A
(en)
|
1970-05-08 |
1975-03-04 |
Nat Res Dev |
Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
|
|
US3950517A
(en)
|
1970-05-08 |
1976-04-13 |
National Research Development Corporation |
Insulin derivatives
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4033941A
(en)
|
1975-12-17 |
1977-07-05 |
Eli Lilly And Company |
Process for purifying glucagon
|
|
GB1492997A
(en)
|
1976-07-21 |
1977-11-23 |
Nat Res Dev |
Insulin derivatives
|
|
JPS6030650B2
(ja)
|
1979-10-26 |
1985-07-17 |
日本油脂株式会社 |
座薬基剤組成物
|
|
JPS5767548A
(en)
|
1980-10-14 |
1982-04-24 |
Shionogi & Co Ltd |
Insulin analog and its preparation
|
|
NL193099C
(nl)
|
1981-10-30 |
1998-11-03 |
Novo Industri As |
Gestabiliseerde insuline-oplossing.
|
|
US4546082A
(en)
|
1982-06-17 |
1985-10-08 |
Regents Of The Univ. Of California |
E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
|
|
US4870008A
(en)
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
|
US4839341A
(en)
|
1984-05-29 |
1989-06-13 |
Eli Lilly And Company |
Stabilized insulin formulations
|
|
DK347086D0
(da)
|
1986-07-21 |
1986-07-21 |
Novo Industri As |
Novel peptides
|
|
PH25772A
(en)
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
|
US4849227A
(en)
|
1986-03-21 |
1989-07-18 |
Eurasiam Laboratories, Inc. |
Pharmaceutical compositions
|
|
PH23446A
(en)
|
1986-10-20 |
1989-08-07 |
Novo Industri As |
Peptide preparations
|
|
NZ222907A
(en)
|
1986-12-16 |
1990-08-28 |
Novo Industri As |
Preparation for intranasal administration containing a phospholipid absorption enhancing system
|
|
DK463887D0
(da)
|
1987-09-07 |
1987-09-07 |
Novo Industri As |
Gaerleader
|
|
US5266310A
(en)
|
1987-09-17 |
1993-11-30 |
Boehringer Ingelheim International Gmbh |
Stabilization of therapeutically active proteins in pharmaceutical preparations
|
|
JPH01254699A
(ja)
|
1988-04-05 |
1989-10-11 |
Kodama Kk |
インスリン誘導体及びその用途
|
|
DK257988D0
(da)
|
1988-05-11 |
1988-05-11 |
Novo Industri As |
Nye peptider
|
|
EP0425482B1
(en)
|
1988-07-20 |
1993-08-18 |
Novo Nordisk A/S |
Human insulin analogs and preparations containing them
|
|
KR0148748B1
(ko)
|
1988-09-16 |
1998-08-17 |
장 크라메르, 한스 루돌프 하우스 |
사이클로스포린을 함유하는 약학조성물
|
|
US5225323A
(en)
|
1988-11-21 |
1993-07-06 |
Baylor College Of Medicine |
Human high-affinity neurotransmitter uptake system
|
|
JPH04502465A
(ja)
|
1988-12-23 |
1992-05-07 |
ノボ ノルディスク アクティーゼルスカブ |
ヒトインシュリン類似物質
|
|
US5716927A
(en)
|
1988-12-23 |
1998-02-10 |
Novo Nordisk A/S |
Insulin analogs having a modified B-chain
|
|
DE3844211A1
(de)
|
1988-12-29 |
1990-07-05 |
Hoechst Ag |
Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
|
DK105489D0
(da)
|
1989-03-03 |
1989-03-03 |
Novo Nordisk As |
Polypeptid
|
|
US5514646A
(en)
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
|
HU210142B
(en)
|
1989-04-20 |
1995-02-28 |
Sinai School Medicine |
Process for producing hepatospecific insulin-analogues and pharmaceutical compositions containing them
|
|
CA1340994C
(en)
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
|
WO1991003935A1
(en)
|
1989-09-22 |
1991-04-04 |
Tsi-Mason Research Institute |
Method and compositions for one-step cryopreservation of embryos
|
|
KR930001305B1
(ko)
|
1989-10-19 |
1993-02-25 |
니뽕 유우시 가부시끼가이샤 |
당 응답형 고분자 복합체(Polymer Complexes of Sugar Response Type)
|
|
US5179189A
(en)
|
1990-01-19 |
1993-01-12 |
Nova Pharmaceutical Corporation |
Fatty acid terminated polyanhydrides
|
|
DK45590D0
(pt)
|
1990-02-21 |
1990-02-21 |
Novo Nordisk As |
|
|
DK155690D0
(da)
|
1990-06-28 |
1990-06-28 |
Novo Nordisk As |
Nye peptider
|
|
DK158390D0
(da)
|
1990-07-02 |
1990-07-02 |
Novo Nordisk As |
Nye peptider
|
|
WO1992001476A1
(en)
|
1990-07-26 |
1992-02-06 |
University Of Iowa Research Foundation |
Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
|
|
WO1992004893A1
(en)
|
1990-09-13 |
1992-04-02 |
Smithkline Beecham Corporation |
Non-aqueous liquid oral suspensions
|
|
DK10191D0
(da)
|
1991-01-22 |
1991-01-22 |
Novo Nordisk As |
Hidtil ukendte peptider
|
|
US5336782A
(en)
|
1991-04-24 |
1994-08-09 |
Kuraray Co., Ltd. |
Long chain carboxylic acid imide ester
|
|
EP0952855B1
(en)
|
1991-07-03 |
2005-07-27 |
Meditech Research Limited |
Use of hyaluronan in gene therapy
|
|
PT100726A
(pt)
|
1991-07-26 |
1993-09-30 |
Smithkline Beecham Corp |
Microemulsoes de agua em oleo, auto-emulsionantes, estaveis e farmaceuticamente aceitaveis e seu uso
|
|
US5268453A
(en)
|
1991-08-08 |
1993-12-07 |
Scios Inc. |
Tissue-selective insulin analogs
|
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
|
NZ245170A
(en)
|
1991-11-26 |
1994-07-26 |
Lilly Co Eli |
Insulin and proinsulin analogues with arg at b31, b32 and ao and pharmaceutical compositions
|
|
DK0547544T3
(da)
*
|
1991-12-18 |
1997-09-08 |
Hoechst Ag |
Fremgangsmåde til fremstilling af insulinholdige opløsninger.
|
|
AU5171293A
(en)
|
1992-10-14 |
1994-05-09 |
Regents Of The University Of Colorado, The |
Ion-pairing of drugs for improved efficacy and delivery
|
|
JPH08502490A
(ja)
|
1992-10-16 |
1996-03-19 |
スミスクライン・ビーチャム・コーポレイション |
組成物
|
|
WO1994008605A1
(en)
|
1992-10-16 |
1994-04-28 |
Smithkline Beecham Corporation |
Therapeutic microemulsions
|
|
EP0684834A4
(en)
|
1993-02-17 |
1996-09-25 |
Smithkline Beecham Corp |
MICROEMULSIONS CONTAINING THERAPEUTIC PEPTIDES.
|
|
EP0684833A4
(en)
|
1993-02-17 |
1996-09-11 |
Smithkline Beecham Corp |
MICRO-EMULSIONS COMPRISING THERAPEUTIC PEPTIDES.
|
|
RU2143889C1
(ru)
|
1993-02-23 |
2000-01-10 |
Генентек, Инк. |
Способ стабилизации полипептида, способы получения композиций полипептида и композиции
|
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
|
DK82893D0
(da)
|
1993-07-08 |
1993-07-08 |
Novo Nordisk As |
Peptid
|
|
DE69428134T2
(de)
|
1993-09-17 |
2002-05-02 |
Novo Nordisk A/S, Bagsvaerd |
Acyliertes insulin
|
|
US6869930B1
(en)
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
|
GB9323588D0
(en)
|
1993-11-16 |
1994-01-05 |
Cortecs Ltd |
Hydrophobic preparation
|
|
ATE416755T1
(de)
|
1994-03-07 |
2008-12-15 |
Nektar Therapeutics |
Verfahren und zusammensetzung für die pulmonale darreichung von insulin
|
|
US5639642A
(en)
|
1994-06-16 |
1997-06-17 |
Novo Nordisk A/S |
Synthetic leader peptide sequences
|
|
IL114160A
(en)
|
1994-06-17 |
2006-12-31 |
Novo Nordisk As |
Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
|
|
US6500645B1
(en)
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
|
US5646242A
(en)
|
1994-11-17 |
1997-07-08 |
Eli Lilly And Company |
Selective acylation of epsilon-amino groups
|
|
US5693609A
(en)
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
|
PL183698B1
(pl)
|
1995-03-17 |
2002-06-28 |
Novo Nordisk As |
Pochodna insuliny, kompozycja farmaceutyczna i zastosowanie pochodnej insuliny
|
|
US5824638A
(en)
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
|
US20010041786A1
(en)
*
|
1995-06-07 |
2001-11-15 |
Mark L. Brader |
Stabilized acylated insulin formulations
|
|
DE69630527T2
(de)
|
1995-06-30 |
2004-08-05 |
Novo Nordisk A/S |
Vorbeugung einer krankheit mit diabetes charakter
|
|
US20030104981A1
(en)
|
1995-11-03 |
2003-06-05 |
Jelena Mandic |
Human insulin analogues
|
|
US6451970B1
(en)
|
1996-02-21 |
2002-09-17 |
Novo Nordisk A/S |
Peptide derivatives
|
|
AU3255397A
(en)
|
1996-07-05 |
1998-02-02 |
Novo Nordisk A/S |
Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides
|
|
ES2230607T3
(es)
|
1996-07-11 |
2005-05-01 |
Novo Nordisk A/S |
Metodo selectivo de acilacion.
|
|
US5981489A
(en)
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
|
PT821006E
(pt)
|
1996-07-26 |
2004-09-30 |
Aventis Pharma Gmbh |
Derivados de insulina com ligacao a zinco aumentada
|
|
IL119029A0
(en)
|
1996-08-07 |
1996-11-14 |
Yeda Res & Dev |
Long-acting drugs and pharamaceutical compositions comprising them
|
|
ATE356830T1
(de)
|
1996-08-30 |
2007-04-15 |
Novo Nordisk As |
Glp-1 derivate
|
|
AU5549998A
(en)
|
1997-01-24 |
1998-08-18 |
Novo Nordisk A/S |
Synthetic leader peptide sequences
|
|
HUP0001013A3
(en)
|
1997-01-30 |
2004-10-28 |
Novartis Ag |
Oil-free pharmaceutical compositions containing cyclosporin a
|
|
US5898067A
(en)
|
1997-02-07 |
1999-04-27 |
Novo Nordisk A/S |
Crystallization of proteins
|
|
US6310038B1
(en)
|
1997-03-20 |
2001-10-30 |
Novo Nordisk A/S |
Pulmonary insulin crystals
|
|
AR012894A1
(es)
|
1997-06-13 |
2000-11-22 |
Lilly Co Eli |
Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
|
|
JP2001521006A
(ja)
|
1997-10-24 |
2001-11-06 |
イーライ・リリー・アンド・カンパニー |
不溶性インシュリン組成物
|
|
RU2218349C2
(ru)
|
1997-10-24 |
2003-12-10 |
Ново Нордиск А/С |
Агрегаты производных инсулина человека
|
|
ZA989744B
(en)
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
|
EP1028706B1
(en)
|
1997-11-12 |
2003-07-09 |
Alza Corporation |
Buffered drug formulations for transdermal electrotransport delivery
|
|
CO4970787A1
(es)
|
1997-12-23 |
2000-11-07 |
Lilly Co Eli |
Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
|
|
JP2002512175A
(ja)
|
1998-02-27 |
2002-04-23 |
ノボ ノルディスク アクティーゼルスカブ |
Ｇｌｐ−１類似体の誘導体類
|
|
CA2334859A1
(en)
|
1998-06-12 |
1999-12-23 |
Kings College London |
Insulin analogue
|
|
GB9814172D0
(en)
|
1998-06-30 |
1998-08-26 |
Andaris Ltd |
Formulation for inhalation
|
|
DK1105460T3
(da)
|
1998-08-10 |
2010-02-08 |
Us Gov Health & Human Serv |
Differentiering af ikke-insulinproducerende celler til insulinproducerende celler med GLP-1 eller Exendin-4 og anvendelser deraf
|
|
AU758351B2
(en)
|
1998-08-25 |
2003-03-20 |
Alkermes, Inc. |
Stable spray-dried protein formulations
|
|
TW570805B
(en)
|
1998-09-01 |
2004-01-11 |
Hoffmann La Roche |
Water-soluble pharmaceutical composition in an ionic complex
|
|
US7030083B2
(en)
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
|
EP1172114B1
(en)
|
1998-10-16 |
2004-09-29 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
|
US7425541B2
(en)
|
1998-12-11 |
2008-09-16 |
Medarex, Inc. |
Enzyme-cleavable prodrug compounds
|
|
PT1146896E
(pt)
|
1999-01-26 |
2002-10-31 |
Lilly Co Eli |
Formulacoes monodispersas de analogo acilado e hexamerico insulina
|
|
AU2879100A
(en)
|
1999-02-12 |
2000-08-29 |
Miles A. Libbey Iii |
Formulation and system for intra-oral delivery of pharmaceutical agents
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
WO2000061178A1
(en)
|
1999-04-13 |
2000-10-19 |
Inhale Therapeutics Systems, Inc. |
Pulmonary administration of dry powder formulations for treating infertility
|
|
WO2000064940A1
(en)
|
1999-04-27 |
2000-11-02 |
Eli Lilly And Company |
Insulin crystals for pulmonary administration
|
|
WO2000069901A2
(en)
|
1999-05-19 |
2000-11-23 |
Xencor, Inc. |
Proteins with insulin-like activity useful in the treatment of diabetes
|
|
US6746853B1
(en)
|
1999-05-19 |
2004-06-08 |
Xencor, Inc. |
Proteins with insulin-like activity useful in the treatment of diabetes
|
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
|
EP1196445A1
(en)
|
1999-06-29 |
2002-04-17 |
Eli Lilly And Company |
Insulin crystals for pulmonary administration
|
|
ATE288765T1
(de)
|
1999-12-16 |
2005-02-15 |
Lilly Co Eli |
Polypeptidzusammensetzungen mit verbesserter stabilität
|
|
AU2001220765A1
(en)
|
2000-01-24 |
2001-07-31 |
Medtronic Minimed, Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
|
US6689747B2
(en)
|
2000-03-24 |
2004-02-10 |
Genentech, Inc. |
Use of insulin for the treatment of cartilagenous disorders
|
|
EP1290024A1
(en)
|
2000-06-02 |
2003-03-12 |
Novo Nordisk A/S |
Glucose dependent release of insulin from glucose sensing insulin derivatives
|
|
CN1141974C
(zh)
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
|
US6459965B1
(en)
|
2000-11-22 |
2002-10-01 |
Ge-Harris Railway Electronics, Llc |
Method for advanced communication-based vehicle control
|
|
KR100508695B1
(ko)
|
2001-02-13 |
2005-08-17 |
한국과학기술연구원 |
인슐린의 경구투여용 제형과 그의 제조방법
|
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
WO2002067969A2
(en)
|
2001-02-21 |
2002-09-06 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
|
CN1160122C
(zh)
|
2001-04-20 |
2004-08-04 |
清华大学 |
一种制备口服胰岛素油相制剂的方法
|
|
AP1763A
(en)
|
2001-05-21 |
2007-08-02 |
Nektar Therapeutics |
Pulmonary administration of chemically modified insulin
|
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
JP2004537580A
(ja)
|
2001-08-10 |
2004-12-16 |
エピックス メディカル， インコーポレイテッド |
延長された循環半減期を有するポリペプチド結合体
|
|
US7030082B2
(en)
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
|
AU2002329989A1
(en)
|
2001-09-07 |
2003-03-24 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US7317000B2
(en)
|
2001-12-02 |
2008-01-08 |
Novo Nordisk A/S |
Glucose-dependent insulins
|
|
JP2005526009A
(ja)
|
2001-12-02 |
2005-09-02 |
ノボ ノルディスク アクティーゼルスカブ |
新規グルコース依存性インスリン
|
|
US8535650B2
(en)
|
2001-12-03 |
2013-09-17 |
Soligenix, Inc. |
Stabilized reverse micelle compositions and uses thereof
|
|
AU2002314790A1
(en)
|
2001-12-05 |
2003-06-23 |
Dow Global Technologies Inc. |
Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
|
|
WO2003053460A1
(en)
|
2001-12-19 |
2003-07-03 |
Eli Lilly And Company |
Crystalline compositions for controlling blood glucose
|
|
CZ2004710A3
(cs)
|
2001-12-20 |
2005-02-16 |
Eli Lilly And Company |
Inzulínová sloučenina s protrahovaným účinkem
|
|
UA46669C2
(uk)
|
2001-12-29 |
2005-12-15 |
Товариство З Обмеженою Відповідальністю "Мако" |
Спосіб приготування готової лікарської форми інсуліну пролонгованої дії
|
|
US8003605B2
(en)
|
2002-03-13 |
2011-08-23 |
Novo Nordisk A/S |
Minimising body weight gain in insulin treatment
|
|
ES2360182T3
(es)
|
2002-05-07 |
2011-06-01 |
Novo Nordisk A/S |
Formulaciones solubles que comprenden insulina monomérica e insulina acilada.
|
|
EP1506003A1
(en)
|
2002-05-07 |
2005-02-16 |
Novo Nordisk A/S |
Soluble formulations comprising insulin aspart and insulin detemir
|
|
US7601688B2
(en)
|
2002-06-13 |
2009-10-13 |
Biocon Limited |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
|
CN1165549C
(zh)
|
2002-06-15 |
2004-09-08 |
江苏万邦生化医药股份有限公司 |
胰岛素的纯化方法
|
|
WO2004026794A2
(en)
|
2002-09-17 |
2004-04-01 |
Merck & Co., Inc. |
Removal of aldehyde impurity by reactive polystyrene resin
|
|
US20040185068A1
(en)
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
|
CN1812808B
(zh)
|
2003-06-03 |
2012-07-04 |
诺沃挪第克公司 |
稳定化的药物肽组合物
|
|
JP2007524592A
(ja)
|
2003-06-03 |
2007-08-30 |
ノボ・ノルデイスク・エー／エス |
安定化された薬学的ペプチド組成物
|
|
US7547821B2
(en)
*
|
2003-06-17 |
2009-06-16 |
Sembiosys Genetics Inc. |
Methods for the production of insulin in plants
|
|
US20050054818A1
(en)
|
2003-07-02 |
2005-03-10 |
Brader Mark Laurence |
Crystalline compositions for controlling blood glucose
|
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
EP2085406A1
(en)
|
2003-07-25 |
2009-08-05 |
ConjuChem Biotechnologies Inc. |
Long lasting insulin derivatives and methods thereof
|
|
AU2004261353B2
(en)
|
2003-08-05 |
2009-12-10 |
Novo Nordisk A/S |
Novel insulin derivatives
|
|
US20060198819A1
(en)
|
2003-08-08 |
2006-09-07 |
Novo Nordisk Healthcare A/G |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
|
PL1660047T3
(pl)
|
2003-08-13 |
2014-05-30 |
Biocon Ltd |
Formulacje dawek stałych mikrocząsteczek soli kwasów tłuszczowych do środków terapeutycznych
|
|
BR122019021416A2
(pt)
|
2003-09-19 |
2019-12-21 |
|
|
|
WO2005047508A1
(en)
|
2003-11-14 |
2005-05-26 |
Novo Nordisk A/S |
Processes for making acylated insulin
|
|
US20050118206A1
(en)
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
|
PL3300721T3
(pl)
|
2003-11-20 |
2019-08-30 |
Novo Nordisk A/S |
Preparaty peptydowe zawierające glikol propylenowy, które są optymalne do produkcji i do zastosowania w urządzeniu do wstrzykiwania
|
|
WO2005058961A2
(en)
|
2003-12-12 |
2005-06-30 |
Amgen Inc. |
Antibodies specific for human galanin, and uses thereof
|
|
DE10358387A1
(de)
|
2003-12-13 |
2005-07-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
|
|
JP4792457B2
(ja)
|
2004-03-26 |
2011-10-12 |
ユニヴァーシタ’デグリ ステュディ ディ パルマ |
高度に呼吸に適したインスリンのマイクロ粒子
|
|
WO2006097793A2
(en)
|
2004-04-15 |
2006-09-21 |
Chiasma, Ltd. |
Compositions capable of facilitating penetration across a biological barrier
|
|
AU2005247369A1
(en)
|
2004-05-10 |
2005-12-08 |
Mdrna, Inc. |
Compositions and methods for enhanced mucosal delivery of parathyroid hormone
|
|
EP2289560B1
(en)
|
2004-07-08 |
2015-04-22 |
Novo Nordisk A/S |
Polypeptide protracting tags comprising a tetrazole moiety
|
|
EP1768694A1
(en)
|
2004-07-09 |
2007-04-04 |
Novo Nordisk A/S |
Phamaceutical preparations comprising insulin
|
|
PL2626368T3
(pl)
|
2004-07-19 |
2017-06-30 |
Biocon Limited |
Koniugaty insulina-oligomer, ich formulacje i zastosowania
|
|
MX2007001589A
(es)
|
2004-08-09 |
2007-08-02 |
Alios Biopharma Inc |
Variantes de polipeptido resistentes a proteasa, hiperglicosiladas sinteticas, formulaciones orales y metodos para utilizar las mismas.
|
|
KR20150039211A
(ko)
|
2004-08-23 |
2015-04-09 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
|
US20080113031A1
(en)
|
2004-09-27 |
2008-05-15 |
Joey Moodley |
Minicapsule Formulations
|
|
EP1817050B1
(en)
|
2004-12-03 |
2015-04-15 |
Rhode Island Hospital |
Diagnosis and treatment of alzheimer's disease
|
|
WO2006079641A2
(en)
|
2005-01-27 |
2006-08-03 |
Novo Nordisk A/S |
Insulin derivatives conjugated with structurally well defined branched polymers
|
|
US20080171695A1
(en)
|
2005-02-02 |
2008-07-17 |
Novo Nordisk A/S |
Insulin Derivatives
|
|
EP2256130B1
(en)
|
2005-02-02 |
2013-09-25 |
Novo Nordisk A/S |
Novel insulin derivatives
|
|
WO2006082245A1
(en)
|
2005-02-07 |
2006-08-10 |
Novo Nordisk A/S |
Pharmaceutical preparations comprising insulin, zinc ions and a zinc-binding ligand
|
|
WO2006086856A1
(en)
|
2005-02-15 |
2006-08-24 |
Messadek, Jallal |
Combination therapeutic compositions and method of use
|
|
TWI372629B
(en)
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
EP1863840A1
(en)
|
2005-03-18 |
2007-12-12 |
Novo Nordisk A/S |
Pegylated single-chain insulin
|
|
WO2006103657A2
(en)
|
2005-03-31 |
2006-10-05 |
Dexcel Pharma Technologies Ltd. |
A solid composition for intra-oral delivery of insulin
|
|
ES2365410T3
(es)
|
2005-04-08 |
2011-10-04 |
Amylin Pharmaceuticals, Inc. |
Formulaciones farmacéuticas que comprenden péptido de incretina y un disolvente polar aprótico.
|
|
JP5235661B2
(ja)
|
2005-05-25 |
2013-07-10 |
ノボ・ノルデイスク・エー／エス |
安定化ポリペプチド製剤
|
|
WO2007006320A1
(en)
|
2005-07-12 |
2007-01-18 |
Sherine Hassan Abbas Helmy |
Drinkable oral insulin liquid and capsules
|
|
US20070086952A1
(en)
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
|
JP4710533B2
(ja)
|
2005-10-07 |
2011-06-29 |
株式会社豊田自動織機 |
牽引車両のドローバー装置
|
|
WO2007047948A2
(en)
|
2005-10-20 |
2007-04-26 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of rapid acting insulin
|
|
DK1969004T3
(da)
|
2005-12-28 |
2011-11-28 |
Novo Nordisk As |
Insulinsammensætninger og metode til at lave en sammensætning
|
|
WO2007081824A2
(en)
|
2006-01-06 |
2007-07-19 |
Case Western Reserve University |
Fibrillation resistant proteins
|
|
WO2007096332A1
(en)
|
2006-02-21 |
2007-08-30 |
Novo Nordisk A/S |
Single-chain insulin analogues and pharmaceutical formulations thereof
|
|
ATE482977T1
(de)
*
|
2006-02-27 |
2010-10-15 |
Novo Nordisk As |
Insulinderivate
|
|
JP2009530242A
(ja)
|
2006-03-13 |
2009-08-27 |
ノボ・ノルデイスク・エー／エス |
アシル化単鎖インスリン
|
|
WO2007104738A2
(en)
|
2006-03-13 |
2007-09-20 |
Novo Nordisk A/S |
Acylated single chain insulin
|
|
RU2451029C2
(ru)
|
2006-05-09 |
2012-05-20 |
Ново Нордиск А/С |
Производное инсулина
|
|
WO2007128815A1
(en)
|
2006-05-09 |
2007-11-15 |
Novo Nordisk A/S |
Insulin derivative
|
|
US20090306337A1
(en)
|
2006-07-31 |
2009-12-10 |
Novo Nordisk A/S |
Pegylated, Extended Insulins
|
|
RU2524150C2
(ru)
|
2006-09-22 |
2014-07-27 |
Ново Нордиск А/С |
Аналоги инсулина, устойчивые к протеазам
|
|
EP2074140B8
(en)
|
2006-10-04 |
2015-10-28 |
Case Western Reserve University |
Fibrillation-resistant insulin and insulin analogues
|
|
JP2010525033A
(ja)
|
2007-04-30 |
2010-07-22 |
ノボ・ノルデイスク・エー／エス |
高濃縮のインスリン溶液及び組成物
|
|
CN101674812B
(zh)
|
2007-04-30 |
2013-12-11 |
诺沃-诺迪斯克有限公司 |
干燥蛋白组合物的方法、干燥的蛋白组合物和包含干燥的蛋白的药物组合物
|
|
EP2164466A1
(en)
|
2007-06-01 |
2010-03-24 |
Novo Nordisk A/S |
Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
|
|
US20100144592A1
(en)
|
2007-06-01 |
2010-06-10 |
Nove Nordisk A/S |
Stable Non-Aqueous Pharmaceutical Compositions
|
|
US9034818B2
(en)
|
2007-06-13 |
2015-05-19 |
Novo Nordisk A/S |
Pharmaceutical formulations comprising an insulin derivative
|
|
US20100216691A1
(en)
|
2007-07-16 |
2010-08-26 |
Novo Nordisk A/S |
Protease Stabilized, Pegylated Insulin Analogues
|
|
WO2009021955A1
(en)
|
2007-08-13 |
2009-02-19 |
Novo Nordisk A/S |
Rapid acting insulin analogues
|
|
US8962794B2
(en)
*
|
2007-08-15 |
2015-02-24 |
Novo Nordisk A/S |
Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
|
|
EP2178912B1
(en)
|
2007-08-15 |
2015-07-08 |
Novo Nordisk A/S |
Insulin analogues with an acyl and aklylene glycol moiety
|
|
US20090087484A1
(en)
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
|
PL2209800T3
(pl)
|
2007-11-16 |
2013-12-31 |
Novo Nordisk As |
Stabilne kompozycje farmaceutyczne zawierające liraglutyd i degludec
|
|
CN101970477B
(zh)
*
|
2008-03-14 |
2014-12-31 |
诺沃-诺迪斯克有限公司 |
蛋白酶稳定的胰岛素类似物
|
|
EP2254906B1
(en)
|
2008-03-18 |
2016-10-05 |
Novo Nordisk A/S |
Protease stabilized, acylated insulin analogues
|
|
US8993516B2
(en)
|
2008-04-14 |
2015-03-31 |
Case Western Reserve University |
Meal-time insulin analogues of enhanced stability
|
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
|
KR20110085985A
(ko)
|
2008-10-30 |
2011-07-27 |
노보 노르디스크 에이/에스 |
하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료
|
|
WO2010060667A1
(en)
|
2008-11-28 |
2010-06-03 |
Novo Nordisk A/S |
Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
|
|
CN102245633A
(zh)
|
2008-12-09 |
2011-11-16 |
诺沃—诺迪斯克有限公司 |
新的胰岛素类似物
|
|
US20120196800A1
(en)
|
2009-09-16 |
2012-08-02 |
Novo Nordisk A/S |
Stable non-aqueous liquid pharmaceutical compositions comprising an insulin
|
|
EP2496213B1
(en)
|
2009-11-02 |
2015-08-12 |
Novo Nordisk A/S |
Pharmaceutical solution of non covalently bound albumin and acylated insulin
|
|
WO2011061125A2
(de)
|
2009-11-23 |
2011-05-26 |
Basf Se |
Verfahren zur herstellung wasserabsorbierender polymerpartikel mit verbesserter farbstabilität
|
|
CN102753150A
(zh)
|
2010-01-12 |
2012-10-24 |
诺沃—诺迪斯克有限公司 |
用于口服给予胰岛素肽的药物组合物
|
|
EP2585484A1
(en)
|
2010-06-23 |
2013-05-01 |
Novo Nordisk A/S |
Insulin analogues containing additional disulfide bonds
|
|
MX337549B
(es)
|
2010-06-23 |
2016-03-10 |
Novo Nordisk As |
Derivados de insulina que contienen enlaces disulfuro adicionales.
|
|
CN103154024A
(zh)
|
2010-10-15 |
2013-06-12 |
诺沃—诺迪斯克有限公司 |
新型n末端修饰的胰岛素衍生物
|
|
JP2013545782A
(ja)
|
2010-12-14 |
2013-12-26 |
ノヴォ ノルディスク アー／エス |
長時間作用型インスリンと組み合わせた速効型インスリン
|
|
US9260503B2
(en)
|
2011-06-15 |
2016-02-16 |
Novo Nordisk A/S |
Multi-substituted insulins
|
|
KR20150002777A
(ko)
|
2012-04-11 |
2015-01-07 |
노보 노르디스크 에이/에스 |
인슐린 제제
|
|
US20150111820A1
(en)
|
2012-07-09 |
2015-04-23 |
Novo Nordisk A/S |
Novel use of insulin derivatives
|
|
JP2016519127A
(ja)
|
2013-04-30 |
2016-06-30 |
ノヴォ ノルディスク アー／エス |
新規投与レジメン
|
|
AU2014333979B2
(en)
|
2013-10-07 |
2018-02-15 |
Novo Nordisk A/S |
Novel derivative of an insulin analogue
|
|
FR3013049B1
(fr)
|
2013-11-14 |
2015-11-13 |
You-Ping Chan |
Analogue de l'insuline glargine
|
|
WO2015131902A1
(en)
|
2014-03-07 |
2015-09-11 |
Jørgensen Klavs Holger |
Novel fast acting insulin preparations
|
|
JO3624B1
(ar)
|
2014-05-08 |
2020-08-27 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
|
TW201630622A
(zh)
|
2014-12-16 |
2016-09-01 |
美國禮來大藥廠 |
速效胰島素組合物
|
|
HRP20211281T1
(hr)
|
2016-12-16 |
2021-11-12 |
Novo Nordisk A/S |
Pripravci koji sadrže inzulin
|